Merck & Co., Inc. (MRK)
USD 98.34
(-1.72%)
USD 98.34
(-1.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 43.98 Billion USD | 5.06% |
| 2022 | 41.87 Billion USD | 19.37% |
| 2021 | 35.07 Billion USD | 25.73% |
| 2020 | 27.9 Billion USD | -14.75% |
| 2019 | 32.72 Billion USD | 13.7% |
| 2018 | 28.78 Billion USD | 5.26% |
| 2017 | 27.34 Billion USD | 5.52% |
| 2016 | 25.91 Billion USD | 5.5% |
| 2015 | 24.56 Billion USD | -3.55% |
| 2014 | 25.46 Billion USD | -5.95% |
| 2013 | 27.07 Billion USD | -12.14% |
| 2012 | 30.82 Billion USD | -1.14% |
| 2011 | 31.17 Billion USD | 12.99% |
| 2010 | 27.59 Billion USD | 49.87% |
| 2009 | 18.4 Billion USD | 0.78% |
| 2008 | 18.26 Billion USD | 1.17% |
| 2007 | 18.05 Billion USD | 8.55% |
| 2006 | 16.63 Billion USD | -1.35% |
| 2005 | 16.86 Billion USD | -6.21% |
| 2004 | 17.97 Billion USD | -1.06% |
| 2003 | 18.17 Billion USD | -3.02% |
| 2002 | 18.73 Billion USD | -0.01% |
| 2001 | 18.73 Billion USD | -2.38% |
| 2000 | 19.19 Billion USD | 19.93% |
| 1999 | 16 Billion USD | 16.64% |
| 1998 | 13.72 Billion USD | 8.2% |
| 1997 | 12.68 Billion USD | 12.84% |
| 1996 | 11.24 Billion USD | 13.63% |
| 1995 | 9.89 Billion USD | 2.1% |
| 1994 | 9.68 Billion USD | 15.52% |
| 1993 | 8.38 Billion USD | 6.33% |
| 1992 | 7.88 Billion USD | 13.79% |
| 1991 | 6.93 Billion USD | 12.76% |
| 1990 | 6.14 Billion USD | 17.72% |
| 1989 | 5.22 Billion USD | 13.07% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 13.4 Billion USD | 6.02% |
| 2024 Q1 | 12.23 Billion USD | 14.15% |
| 2024 Q2 | 11.86 Billion USD | -3.04% |
| 2023 Q4 | 10.71 Billion USD | -8.38% |
| 2023 Q2 | 11.01 Billion USD | 4.26% |
| 2023 Q1 | 10.56 Billion USD | 6.15% |
| 2023 Q3 | 11.69 Billion USD | 6.24% |
| 2023 FY | 43.98 Billion USD | 5.06% |
| 2022 Q4 | 9.94 Billion USD | -9.76% |
| 2022 FY | 41.87 Billion USD | 19.37% |
| 2022 Q2 | 10.37 Billion USD | -1.37% |
| 2022 Q3 | 11.02 Billion USD | 6.24% |
| 2022 Q1 | 10.52 Billion USD | 9.06% |
| 2021 FY | 35.07 Billion USD | 25.73% |
| 2021 Q1 | 7.42 Billion USD | 6.39% |
| 2021 Q2 | 8.29 Billion USD | 11.71% |
| 2021 Q3 | 9.7 Billion USD | 16.94% |
| 2021 Q4 | 9.64 Billion USD | -0.59% |
| 2020 Q2 | 6.6 Billion USD | -24.46% |
| 2020 FY | 27.9 Billion USD | -14.75% |
| 2020 Q1 | 8.74 Billion USD | 6.66% |
| 2020 Q3 | 7.91 Billion USD | 19.83% |
| 2020 Q4 | 6.98 Billion USD | -11.8% |
| 2019 Q1 | 7.76 Billion USD | 0.71% |
| 2019 Q2 | 8.35 Billion USD | 7.66% |
| 2019 Q3 | 8.4 Billion USD | 0.57% |
| 2019 FY | 32.72 Billion USD | 13.7% |
| 2019 Q4 | 8.19 Billion USD | -2.47% |
| 2018 Q2 | 7.04 Billion USD | 2.85% |
| 2018 FY | 28.78 Billion USD | 5.26% |
| 2018 Q1 | 6.85 Billion USD | -2.48% |
| 2018 Q3 | 7.17 Billion USD | 1.8% |
| 2018 Q4 | 7.7 Billion USD | 7.44% |
| 2017 Q4 | 7.02 Billion USD | 0.13% |
| 2017 FY | 27.34 Billion USD | 5.52% |
| 2017 Q1 | 6.38 Billion USD | -5.87% |
| 2017 Q2 | 6.81 Billion USD | 6.72% |
| 2017 Q3 | 7.01 Billion USD | 2.99% |
| 2016 Q3 | 7.12 Billion USD | 13.74% |
| 2016 FY | 25.91 Billion USD | 5.5% |
| 2016 Q2 | 6.26 Billion USD | 9.16% |
| 2016 Q4 | 6.78 Billion USD | -4.83% |
| 2016 Q1 | 5.74 Billion USD | -9.82% |
| 2015 Q4 | 6.36 Billion USD | 0.84% |
| 2015 Q2 | 6.03 Billion USD | 2.99% |
| 2015 Q1 | 5.85 Billion USD | -13.03% |
| 2015 FY | 24.56 Billion USD | -3.55% |
| 2015 Q3 | 6.31 Billion USD | 4.66% |
| 2014 FY | 25.46 Billion USD | -5.95% |
| 2014 Q3 | 6.33 Billion USD | 4.85% |
| 2014 Q2 | 6.04 Billion USD | -5.03% |
| 2014 Q1 | 6.36 Billion USD | -5.24% |
| 2014 Q4 | 6.73 Billion USD | 6.3% |
| 2013 FY | 27.07 Billion USD | -12.14% |
| 2013 Q1 | 6.71 Billion USD | -11.42% |
| 2013 Q4 | 6.71 Billion USD | -3.1% |
| 2013 Q3 | 6.92 Billion USD | 3.0% |
| 2013 Q2 | 6.72 Billion USD | 0.21% |
| 2012 Q3 | 7.35 Billion USD | -10.34% |
| 2012 Q4 | 7.57 Billion USD | 3.07% |
| 2012 FY | 30.82 Billion USD | -1.14% |
| 2012 Q1 | 7.69 Billion USD | -5.22% |
| 2012 Q2 | 8.19 Billion USD | 6.56% |
| 2011 Q1 | 7.52 Billion USD | -1.73% |
| 2011 Q4 | 8.11 Billion USD | 5.84% |
| 2011 Q2 | 7.86 Billion USD | 4.6% |
| 2011 Q3 | 7.67 Billion USD | -2.5% |
| 2011 FY | 31.17 Billion USD | 12.99% |
| 2010 Q2 | 6.79 Billion USD | 9.52% |
| 2010 Q3 | 6.93 Billion USD | 2.02% |
| 2010 Q4 | 7.65 Billion USD | 10.38% |
| 2010 FY | 27.59 Billion USD | 49.87% |
| 2010 Q1 | 6.2 Billion USD | 19.52% |
| 2009 Q3 | 4.61 Billion USD | 1.61% |
| 2009 Q4 | 5.19 Billion USD | 12.41% |
| 2009 Q2 | 4.54 Billion USD | 12.21% |
| 2009 Q1 | 4.05 Billion USD | -11.2% |
| 2009 FY | 18.4 Billion USD | 0.78% |
| 2008 Q4 | 4.56 Billion USD | 2.16% |
| 2008 FY | 18.26 Billion USD | 1.17% |
| 2008 Q3 | 4.46 Billion USD | -4.07% |
| 2008 Q1 | 4.58 Billion USD | -2.43% |
| 2008 Q2 | 4.65 Billion USD | 1.56% |
| 2007 Q3 | 4.55 Billion USD | -0.06% |
| 2007 FY | 18.05 Billion USD | 8.55% |
| 2007 Q1 | 4.24 Billion USD | -3.0% |
| 2007 Q2 | 4.55 Billion USD | 7.43% |
| 2007 Q4 | 4.69 Billion USD | 3.11% |
| 2006 Q4 | 4.37 Billion USD | 13.16% |
| 2006 FY | 16.63 Billion USD | -1.35% |
| 2006 Q3 | 3.86 Billion USD | -10.64% |
| 2006 Q2 | 4.32 Billion USD | 6.38% |
| 2006 Q1 | 4.06 Billion USD | -5.13% |
| 2005 Q3 | 4.17 Billion USD | -3.01% |
| 2005 Q2 | 4.3 Billion USD | 5.28% |
| 2005 Q1 | 4.09 Billion USD | -8.37% |
| 2005 FY | 16.86 Billion USD | -6.21% |
| 2005 Q4 | 4.28 Billion USD | 2.63% |
| 2004 Q4 | 4.46 Billion USD | 6.96% |
| 2004 Q3 | 4.17 Billion USD | -14.08% |
| 2004 Q2 | 4.85 Billion USD | 8.37% |
| 2004 Q1 | 4.48 Billion USD | 1.91% |
| 2004 FY | 17.97 Billion USD | -1.06% |
| 2003 Q4 | 4.39 Billion USD | -5.98% |
| 2003 FY | 18.17 Billion USD | -3.02% |
| 2003 Q2 | 4.53 Billion USD | 1.02% |
| 2003 Q3 | 4.67 Billion USD | 3.12% |
| 2003 Q1 | 4.49 Billion USD | -13.93% |
| 2002 Q3 | 4.45 Billion USD | -1.42% |
| 2002 FY | 18.73 Billion USD | -0.01% |
| 2002 Q4 | 5.21 Billion USD | 17.19% |
| 2002 Q2 | 4.51 Billion USD | 7.84% |
| 2002 Q1 | 4.18 Billion USD | -14.79% |
| 2001 Q3 | 4.83 Billion USD | 3.17% |
| 2001 Q4 | 4.91 Billion USD | 1.63% |
| 2001 FY | 18.73 Billion USD | -2.38% |
| 2001 Q1 | 4.29 Billion USD | -21.14% |
| 2001 Q2 | 4.68 Billion USD | 9.07% |
| 2000 Q3 | 4.85 Billion USD | 4.89% |
| 2000 Q2 | 4.63 Billion USD | 8.72% |
| 2000 Q1 | 4.25 Billion USD | -5.84% |
| 2000 Q4 | 5.45 Billion USD | 12.22% |
| 2000 FY | 19.19 Billion USD | 19.93% |
| 1999 Q3 | 4.03 Billion USD | 4.53% |
| 1999 Q2 | 3.86 Billion USD | 7.77% |
| 1999 FY | 16 Billion USD | 16.64% |
| 1999 Q4 | 4.52 Billion USD | 12.04% |
| 1999 Q1 | 3.58 Billion USD | -8.96% |
| 1998 Q4 | 3.93 Billion USD | 19.51% |
| 1998 Q2 | 3.08 Billion USD | 9.34% |
| 1998 FY | 13.72 Billion USD | 8.2% |
| 1998 Q3 | 3.29 Billion USD | 6.71% |
| 1998 Q1 | 2.82 Billion USD | -29.43% |
| 1997 Q2 | 2.96 Billion USD | 6.59% |
| 1997 FY | 12.68 Billion USD | 12.84% |
| 1997 Q3 | 2.93 Billion USD | -0.95% |
| 1997 Q4 | 4 Billion USD | 36.22% |
| 1997 Q1 | 2.78 Billion USD | -24.06% |
| 1996 FY | 11.24 Billion USD | 13.63% |
| 1996 Q2 | 2.62 Billion USD | 14.26% |
| 1996 Q3 | 2.65 Billion USD | 1.14% |
| 1996 Q4 | 3.66 Billion USD | 37.97% |
| 1996 Q1 | 2.29 Billion USD | -25.85% |
| 1995 Q1 | 2.09 Billion USD | -30.91% |
| 1995 Q3 | 2.31 Billion USD | -3.21% |
| 1995 FY | 9.89 Billion USD | 2.1% |
| 1995 Q4 | 3.09 Billion USD | 33.96% |
| 1995 Q2 | 2.38 Billion USD | 14.28% |
| 1994 Q4 | 3.02 Billion USD | 29.33% |
| 1994 FY | 9.68 Billion USD | 15.52% |
| 1994 Q1 | 2.05 Billion USD | -19.22% |
| 1994 Q2 | 2.26 Billion USD | 9.94% |
| 1994 Q3 | 2.34 Billion USD | 3.39% |
| 1993 Q1 | 1.84 Billion USD | -21.07% |
| 1993 Q2 | 1.99 Billion USD | 7.99% |
| 1993 FY | 8.38 Billion USD | 6.33% |
| 1993 Q4 | 2.54 Billion USD | 27.08% |
| 1993 Q3 | 2 Billion USD | 0.77% |
| 1992 Q1 | 1.75 Billion USD | -14.79% |
| 1992 Q2 | 1.84 Billion USD | 5.1% |
| 1992 FY | 7.88 Billion USD | 13.79% |
| 1992 Q3 | 1.94 Billion USD | 5.51% |
| 1992 Q4 | 2.33 Billion USD | 19.83% |
| 1991 Q4 | 2.06 Billion USD | 26.42% |
| 1991 FY | 6.93 Billion USD | 12.76% |
| 1991 Q3 | 1.63 Billion USD | -4.96% |
| 1991 Q2 | 1.71 Billion USD | 3.78% |
| 1991 Q1 | 1.65 Billion USD | -11.47% |
| 1990 FY | 6.14 Billion USD | 17.72% |
| 1990 Q4 | 1.86 Billion USD | 27.0% |
| 1990 Q3 | 1.47 Billion USD | 0.84% |
| 1990 Q2 | 1.45 Billion USD | 8.09% |
| 1990 Q1 | 1.34 Billion USD | -14.37% |
| 1989 Q1 | 1.57 Billion USD | 2.43% |
| 1989 Q4 | 1.57 Billion USD | 27.41% |
| 1989 Q3 | 1.23 Billion USD | -21.97% |
| 1989 FY | 5.22 Billion USD | 13.07% |
| 1989 Q2 | 1.58 Billion USD | 0.88% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbbVie Inc. | 45.53 Billion USD | 3.402% |
| Bristol-Myers Squibb Company | 34.31 Billion USD | -28.199% |
| Bristol-Myers Squibb Company Ce | 34.31 Billion USD | -28.199% |
| Johnson & Johnson | 58.6 Billion USD | 24.941% |
| Eli Lilly and Company | 27.04 Billion USD | -62.67% |
| Novartis AG | 34.18 Billion USD | -28.668% |
| Organon & Co. | 3.74 Billion USD | -1073.666% |
| Pfizer Inc. | 28.8 Billion USD | -52.692% |